Nestlé Health Science and Enterome are jointly creating Microbiome Diagnostics Partners. The new partnership aims to lead the development and commercialisation of microbiome-based diagnostic innovations for a range of conditions such as inflammatory bowel diseases and liver diseases.
Read more on the Nestlé Health Science website